发明名称 Na+/K+-ATPase-specific peptide inhibitors/activators of Src and Src family kinases
摘要 A method for regulating Src and its downstream signaling pathway which includes binding between Src and Na+/K+-ATPase is disclosed. The Na+/K+-ATPase/Src complex is a functional receptor for cardiotonic steroids such as ouabain. Also disclosed are Src inhibitors or activators which include either Na+/K+-ATPase or Src that interfere with the interaction between the Na/K-ATPase and Src, act via a different mechanism from ATP analogs, and is pathway (Na+/K+-ATPase) specific.
申请公布号 US8981051(B2) 申请公布日期 2015.03.17
申请号 US201213625162 申请日期 2012.09.24
申请人 The University of Toledo 发明人 Xie Zi-Jian;Shapiro Joseph I.;Tian Jiang;Li Zhichuan
分类号 A61K38/10;C07K14/47;A61K38/45;A61K38/46;C07K7/08;G01N33/573 主分类号 A61K38/10
代理机构 MacMillan, Sobanski & Todd, LLC 代理人 MacMillan, Sobanski & Todd, LLC
主权项 1. A pharmaceutical composition for regulation of one or more signaling pathways involved in fibrosis, the composition comprising: one or more Src and Src family kinases inhibitors comprised of one or more isolated peptides, or fragments thereof, that do not inhibit the ion pumping function of Na+/K+-ATPase; wherein the one or more isolated peptides comprises the active isolated Src-inhibitory peptide (P3) consisting of the amino acid sequence of SEQ ID NO: 2.
地址 Toledo OH US